Document Detail


Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
MedLine Citation:
PMID:  22170618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Roux-en-Y gastric bypass (RYGB) surgery has been shown to decrease consummatory responsiveness of rats to high sucrose concentrations, and genetic deletion of glucagon-like peptide-1 receptors (GLP-1R) has been shown to decrease consummatory responsiveness of mice to low-sucrose concentrations. Here we assessed the effects of RYGB and pharmacological GLP-1R modulation on sucrose licking by chow-fed rats in a brief-access test that assessed consummatory and appetitive behaviors. Rats were tested while fasted presurgically and postsurgically and while nondeprived postsurgically and 5 h after intraperitoneal injections with the GLP-1R antagonist exendin-3(9-39) (30 μg/kg), agonist exendin-4 (1 μg/kg), and vehicle in 30-min sessions during which a sucrose concentration series (0.01-1.0 M) was presented in 10-s trials. Other rats were tested postsurgically or 15 min after peptide or vehicle injection while fasted and while nondeprived. Independent of food-deprivation state, sucrose experience, or GLP-1R modulation, RYGB rats took 1.5-3× as many trials as sham-operated rats, indicating increased appetitive behavior. Under nondeprived conditions, RYGB rats with presurgical sucrose experience licked more to sucrose relative to water compared with sham-operated rats. Exendin-4 and exendin-3(9-39) impacted 0.3 M sucrose intake in a one-bottle test, but never interacted with surgical group to affect brief-access responding. Unlike prior reports in both clearly obese and relatively leaner rats given RYGB and in GLP-1R knockout mice, we found that neither RYGB nor GLP-1R blockade decreased consummatory responsiveness to sucrose in our less obese chow-fed rats. Collectively, these results highlight the fact that changes in taste-driven motivated behavior to sucrose after RYGB and/or GLP-1R modulation are very model and measure dependent.
Authors:
C M Mathes; M Bueter; K R Smith; T A Lutz; C W le Roux; A C Spector
Related Documents :
9834838 - A role of nerve growth factor in oligodendrocyte growth and differentiation of eae affe...
9667228 - Effect of immunosuppression on kidney and serum insulin-like growth factor-i (igf-i), i...
1317768 - Effects of epidermal growth factor and glutamine-supplemented parenteral nutrition on t...
8880218 - Construction of a sensitive enzyme immunoassay for human fibroblast growth factor 9.
17379248 - Effective treatment of experimental autoimmune neuritis with human immunoglobulin.
16416308 - Heterogeneous occurrence of aquaporin-4 in the ependyma and in the circumventricular or...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2011-12-14
Journal Detail:
Title:  American journal of physiology. Regulatory, integrative and comparative physiology     Volume:  302     ISSN:  1522-1490     ISO Abbreviation:  Am. J. Physiol. Regul. Integr. Comp. Physiol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-16     Completed Date:  2012-05-15     Revised Date:  2013-03-19    
Medline Journal Info:
Nlm Unique ID:  100901230     Medline TA:  Am J Physiol Regul Integr Comp Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  R751-67     Citation Subset:  IM    
Affiliation:
Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306-4301,USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Appetite / drug effects,  physiology
Behavior, Animal / drug effects*,  physiology
Dose-Response Relationship, Drug
Drinking / physiology
Eating / drug effects,  physiology
Gastric Bypass*
Injections, Intraperitoneal
Male
Models, Animal
Peptide Fragments / administration & dosage,  pharmacology*
Peptides / administration & dosage,  pharmacology*
Rats
Rats, Sprague-Dawley
Receptors, Glucagon / agonists,  antagonists & inhibitors,  drug effects*
Sucrose / pharmacology*
Time Factors
Venoms / administration & dosage,  pharmacology*
Grant Support
ID/Acronym/Agency:
F32DC010517-01/DC/NIDCD NIH HHS
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/Peptides; 0/Receptors, Glucagon; 0/Venoms; 0/glucagon-like peptide-1 receptor; 133514-43-9/exendin (9-39); 141732-76-5/exenatide; 57-50-1/Sucrose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.
Next Document:  Divergent roles of plasma osmolality and the baroreflex on sweating and skin blood flow.